START FREE TRIAL

Meta & Nebius Show Why AI’s Biggest Constraint Isn’t Chips!

The artificial intelligence boom has created a new kind of gold rush. Companies are racing to build models, train...

Did Markets Misread Intuit’s Position In The AI Era?

Markets love a good villain. Right now, artificial intelligence has become the monster hiding under every software company’s bed....

Did Apple’s MotionVFX Acquisition Just DEEPEN Its Creator Ecosystem Moat?

Apple (NASDAQ:AAPL) has been busy giving investors plenty to chew on. The company just posted a record quarter, with...

Trump Wants Allies’ Help For Hormuz — THESE Stocks May React Next!

The Iran war has turned a narrow shipping corridor into one of the most important forces shaping global markets. Roughly...

Progress Software Might Be The “Boring” Tech Stock Private Equity Loves Most

Rumors have been circulating around Progress Software (NASDAQ:PRGS). Some traders believe private equity giant Thoma Bravo may be looking...

The $40 Billion Parenting Arms Race Is Powering Dick’s Sporting Goods!

Walk into a youth baseball tournament today and something feels different. The kids still play the same game. But...

Is Tesla Quietly Building A Utility Business Behind Its EV Brand?

Most people still think of Tesla (NASDAQ:TSLA) as a car company. That perceptiotesla-quietly-becoming-electric-utilityn made sense a few years ago....

The Strait of Hormuz Effect: The Quiet Rotation Into REITs & Dividends Has Already Begun!

The market’s first reaction to the Iran war was predictable. Oil surged above $100 per barrel, global equities slipped,...

Amazon Is Preparing For A World Where Websites DON’T MATTER!

Something unusual is happening on the internet. And if you blink, you might miss it. For nearly three decades, the...

NVIDIA’s Real Business Isn’t Chips—It’s AI Factories!

The story most investors tell about Nvidia (NASDAQ:NVDA) is simple. It sells the picks and shovels of the AI...

Is Meta’s Moltbook Deal About Social Media … Or The Future Of AI Agents?

Recent developments around Meta Platforms (NASDAQ:META) suggest the company is continuing its aggressive push into artificial intelligence infrastructure and...

Agilent’s $950M Biocare Acquisition Could Unlock A Powerful Recurring Revenue Flywheel

The diagnostics and life sciences equipment industry rarely stands still. But recent developments around Agilent Technologies (NYSE:A) have drawn...